Optimizing the Patient Journey Through High-Tech, High-Touch Services
Empower patient adherence solutions with digital tools and personal connection
- 2 min read
The number of novel and innovative therapies that are approved each year continues to grow. The financial and long-term adherence barriers for these products present new challenges that require intelligent, proactive patient support.
UBC’s Vice President of Patient Access & Strategic Engagement Dana Edwards discusses the critical points of balancing personal connection and technological efficiencies in the latest whitepaper from UBC.
Topics covered include:
- The Importance of Guiding the Patient Journey
- Digital Solutions to Enhance Patient Services
- Balancing Technology & Empathy
- Patients First Program Design
How can high-tech, high-touch strategies enhance patient adherence and affordability?
Using digital tools allows biopharmaceutical companies to easily reach patients and provide patient support programs. But getting the best results also requires holistic patient resources that support the patient journey, including patient access, adherence and affordability solutions. Explore how to balance digital tools with empathetic connections and make an impact.
Enabling pharma patient access to drive better outcomes
UBC’s patient access and engagement services approach your therapy collaboratively, seeking to create individualized solutions to help your patients and prescribers. We look forward to helping you define ways to drive improved access and adherence to support your brand objectives. Learn more about our Patient Access Services or get in touch with us.
Download the Whitepaper
Related Resources
- 1 min read
For evidence generation teams working to JCA timelines: this white paper sets out the expert-guided model for AI-assisted literature review, the eight stages where technology accelerates and experts decide, the governance that keeps reviews auditable, and where seven HTA bodies currently stand on AI.
- 9 min read
Explore how lifecycle HTA evaluates health technologies as evidence matures, and how real-world evidence, patient-reported outcomes, and equity move from supporting detail to core inputs in value and reassessment decisions.
- 10 min read
For PV leaders navigating AI adoption: this white paper maps real-world use cases across case processing, safety reporting, and regulatory intelligence, alongside the security, validation, and build-versus-buy decisions that come with them. Plus the centaur model, where human oversight stays non-negotiable.
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.